Gambling disorder is the persistent, maladaptive pattern of gambling that disrupts personal, family, or occupational functioning, and it is the only behavioral addiction recognized alongside the substance use disorders in DSM-5-TR. Its reclassification from an impulse-control disorder to a Substance-Related and Addictive Disorders condition in DSM-5 reflected converging evidence that compulsive gambling engages the same mesolimbic reward circuitry as drugs of abuse. Lifetime prevalence in the general adult population sits near 0.4 to 1.0 percent, but rates are several-fold higher in psychiatric and substance-use populations and among patients on dopamine-agonist therapy. Diagnosis rests on a 12-month pattern with at least four of nine criteria, and suicide risk is substantially elevated and should be screened at every encounter. Cognitive-behavioral therapy is the best-supported treatment, with no medication holding an FDA indication for this disorder. The clinical bottom line: ask about gambling in any patient with mood, substance, or financial crisis, and treat the disorder as an addiction, not a vice.

Gambling disorder is uncommon at the population level but heavily over-represented in psychiatric, substance-use, and forensic populations. The clinician should suspect it whenever financial crisis accompanies a mood or substance presentation.^[2-3]

Prevalence

• Lifetime prevalence in the general adult population is approximately 0.4 to 1.0 percent across most national surveys, with past-year prevalence near 0.2 to 0.6 percent.^[2]
• Past-year problem and pathological gambling rates rise to 5 to 15 percent in patients with substance use disorders and roughly 5 percent in patients with mood disorders.^[3]
• Rates among Parkinson disease patients treated with Dopamine agonist therapy reach 5 to 8 percent for any impulse-control disorder, with pathological gambling a leading subtype.^[4]

Demographics

• Male predominance is consistent at roughly 2:1, with earlier age of onset (late adolescence to mid-20s) in men and later onset (30s to 50s) in women.^[2-3]
• Women show a faster progression from initiation to disordered gambling (the so-called telescoping effect) similar to that seen in alcohol use disorder.^[3]
• Strategic forms (sports betting, poker) predominate in men; non-strategic forms (slots, bingo, scratch cards) predominate in women.^[5]

Comorbidity

• Lifetime comorbidity with any substance use disorder approaches 60 to 75 percent in clinical samples; nicotine and alcohol use disorders are the most frequent.^[2-3]
• Mood disorders co-occur in roughly 35 to 50 percent of cases; anxiety disorders in 35 to 60 percent.^[2]
• Cluster B personality disorders, particularly antisocial and borderline, are over-represented.^[5]

Risk factors

• Family history of gambling, substance use, or mood disorders.^[2]
• Early exposure to gambling, particularly an early winning experience.^[3]
• Male sex, single status, lower socioeconomic status, and proximity to gambling venues.^[2-3]
• Iatrogenic exposure to dopamine agonists (pramipexole, ropinirole, rotigotine) and, less consistently, aripiprazole.^[4,6]

Gambling disorder is the prototypical behavioral addiction, sharing neurobiology, genetics, and treatment response with substance use disorders. The mechanistic story centers on the Reward circuit and its frontal regulatory inputs.^[2,6]

Neurobiology

• Functional imaging shows blunted ventral striatal response to monetary reward at baseline with exaggerated response to gambling-specific cues, mirroring patterns in substance addictions.^[2]
• Hypoactivation of the ventromedial prefrontal cortex and dorsolateral prefrontal cortex contributes to impaired decision-making, loss-chasing, and risk underestimation.^[2,6]
• Dopaminergic dysregulation is central; near-miss outcomes activate striatal regions as strongly as actual wins, helping explain reinforcement by losses.^[6]
• Opioid and glutamatergic systems modulate craving and reinforcement, providing the rationale for naltrexone and N-acetylcysteine trials.^[6-7]
• Serotonergic dysfunction is implicated in the impulsivity dimension and provides a rationale for SSRI trials, though efficacy data are mixed.^[11]

Genetics

• Twin studies estimate heritability at 50 to 60 percent, comparable to alcohol use disorder.^[2]
• Substantial genetic overlap with alcohol and other substance use disorders supports the shared-addiction-vulnerability model.^[2-3]
• No single gene of large effect has been identified; candidate associations include dopamine and serotonin pathway genes.^[5]

Environmental and developmental factors

• Early exposure to gambling and an early big win predict later disorder.^[3]
• Childhood adversity, including abuse and parental gambling, increases risk.^[3]
• Availability and accessibility (online platforms, in-play sports betting, electronic gaming machines) are robust ecological risk factors.^[3]

Integrative model

• Gambling disorder is best conceptualized as the interaction of inherited reward-system vulnerability, early reinforcement experience, gambling-specific cognitive distortions, and environmental accessibility, with progression accelerated by comorbid mood and substance pathology.^[2-3,6]

DSM-5-TR places gambling disorder in the Substance-Related and Addictive Disorders chapter, the only behavioral addiction so classified. Diagnosis requires a persistent and recurrent maladaptive pattern over 12 months that is not better explained by a manic episode.^[1]

Threshold and specifiers

• At least 4 of 9 criteria must be present within a 12-month period; severity is graded mild (4-5 criteria), moderate (6-7), or severe (8-9).^[1]
• Course specifiers: episodic (meeting criteria at more than one time point with at least several months of partial remission between) versus persistent (continuous symptoms for multiple years).^[1]
• Remission specifiers: early remission (3 to less than 12 months without criteria) and sustained remission (12 months or more).^[1]
• An environment specifier (in a controlled environment) is also defined for restricted settings such as inpatient or correctional facilities.^[1]

The nine criteria (paraphrased)

• Needing to gamble with increasing amounts of money to achieve the desired excitement (tolerance).^[1]
• Restless or irritable when attempting to cut down or stop (withdrawal-like).^[1]
• Repeated unsuccessful efforts to control, cut back, or stop gambling.^[1]
• Preoccupation with gambling (reliving past experiences, planning the next venture, thinking of ways to get money).^[1]
• Gambling when feeling distressed (helpless, guilty, anxious, depressed).^[1]
• After losing money, often returning another day to get even (chasing losses).^[1]
• Lying to conceal the extent of gambling involvement.^[1]
• Jeopardizing or losing a significant relationship, job, or educational or career opportunity because of gambling.^[1]
• Relying on others to provide money to relieve desperate financial situations (a bailout).^[1]

Changes from DSM-IV and ICD-11 differences

• DSM-IV pathological gambling required 5 of 10 criteria; DSM-5 lowered the threshold to 4 of 9 and removed the illegal acts criterion based on low prevalence and weak factor loading.^[1,3]
• DSM-5 moved the diagnosis from Impulse-Control Disorders Not Elsewhere Classified into the Substance-Related and Addictive Disorders chapter.^[1,3]
• ICD-11 lists gambling disorder under Disorders due to addictive behaviors and offers predominantly offline and predominantly online subtypes.^[8]

The presentation is typically driven by a financial or relational crisis rather than self-referral. The clinician should expect concealment, minimization, and presentation through a comorbid disorder.^[3,5]

Typical presentation

• Patients often present after a precipitating loss, a confrontation by family, a legal problem, or a suicide attempt.^[3]
• Concealment is near-universal; family members frequently provide more accurate history than the patient.^[5]
• Mood symptoms, insomnia, and substance use commonly bring the patient to attention before the gambling itself is disclosed.^[2-3]

Cognitive distortions

• The gambler's fallacy is the belief that prior independent outcomes alter future probabilities (e.g., red is due after a run of black).^[6]
• The illusion of control is the belief that personal skill, ritual, or talisman can influence chance outcomes.^[6]
• Overvaluation of near-misses, selective recall of wins, and entrapment (the sunk-cost-driven need to keep playing to recoup losses) are core targets of cognitive-behavioral therapy.^[6,13]

Course and stages

• A winning phase (often with an early big win), followed by a losing phase with chasing, a desperation phase with bailouts and illegal acts, and a hopeless phase with depression and suicidality is the classical Custer staging; not all patients progress through every stage.^[5]
• Spontaneous remission occurs in a meaningful minority, particularly with milder cases and supportive social context.^[2]

Red flags

• Unexplained financial loss, missing assets, secretive phone or internet use, lying about whereabouts.^[5]
• New onset of impulsive gambling in a patient on a dopamine agonist or recently started aripiprazole.^[4,6]
• Active suicidality in a patient with recent gambling losses; treat as a high-acuity presentation.^[2]

The most consequential distinctions are from bipolar mania, iatrogenic dopamine-agonist effects, and frontal lobe pathology. A 12-month longitudinal frame and a medication history are the keys.^[1,4]

Primary psychiatric differentials

• Bipolar disorder, manic or hypomanic episode: gambling driven by elevated or expansive mood, decreased need for sleep, grandiosity, and pressured speech; gambling disorder is not diagnosed if the behavior occurs only during mood episodes.^[1]
• Substance use disorder: gambling can co-occur with or be amplified by intoxication; both diagnoses may be made if criteria are independently met.^[1]
• Antisocial personality disorder: long-standing pattern of disregard for rights of others, often including reckless gambling; both can coexist.^[1,5]
• Obsessive-compulsive disorder: compulsions are ego-dystonic and not pleasurable, distinguishing them from gambling urges.^[5]
• Recreational and professional gambling: do not meet impairment or distress criteria, with disciplined budgeting and absence of chasing or concealment.^[1]

Iatrogenic and secondary causes

• Dopamine-agonist therapy in Parkinson disease (pramipexole, ropinirole, rotigotine, apomorphine): onset typically within months of initiation or dose escalation; reversible on dose reduction.^[4]
• Aripiprazole and, less commonly, brexpiprazole: partial dopamine agonism has been associated with new-onset pathological gambling; the FDA added a warning in 2016.^[6]
• Levodopa in Parkinson disease: lower risk than dopamine agonists but documented.^[4]

Medical and neurologic differentials

• Frontal lobe lesions (stroke, tumor, traumatic brain injury) producing disinhibition.^[5]
• Behavioral variant frontotemporal dementia: early disinhibition, including new-onset gambling.^[5]
• Huntington disease and other basal-ganglia disorders can produce impulse-control symptoms.^[5]

Assessment is structured around case-finding, severity grading, comorbidity, and safety. A focused screen takes under two minutes and should be embedded in any addiction, mood, or financial-crisis evaluation.^[9]

Screening tools

• Lie/Bet Questionnaire: 2 items asking about lying to important others about gambling and the need to bet increasing amounts; a positive answer to either is highly sensitive for case-finding.^[9]
• South Oaks Gambling Screen (SOGS): 20-item self-report; widely used historically and in research; a score of 5 or higher indicates probable pathological gambling.^[10]
• Problem Gambling Severity Index (PGSI): 9-item past-12-month measure within the Canadian Problem Gambling Index; categorizes non-problem, low-risk, moderate-risk, and problem gambling.^[5]
• NORC DSM Screen for Gambling Problems (NODS): 17-item structured measure based directly on DSM criteria.^[5]

History to obtain

• Gambling forms (strategic versus non-strategic), frequency, money spent, debt accumulated, time gambling, and online versus in-person exposure.^[5]
• Onset, course, prior treatment, prior periods of abstinence, and triggers for relapse.^[5]
• Comorbid substance use (especially alcohol and nicotine), mood, anxiety, trauma, and personality disorder symptoms.^[2,5]
• Suicidal ideation, plan, intent, prior attempts, and access to lethal means; financial crisis is a major precipitant.^[2]
• Legal problems, recent illegal acts to fund gambling, and family-of-origin gambling history.^[5]
• Medication review with explicit attention to dopamine agonists and aripiprazole.^[4,6]

Physical and laboratory evaluation

• Screen for substance use with a focused history; consider urine toxicology if intoxication or covert use is suspected.^[5]
• Standard general medical workup as indicated; routine neuroimaging is not required unless focal neurologic signs, new-onset late-life gambling, or other red flags suggest a frontal lesion or dementia.^[5]
• TSH, CBC, BMP, and HbA1c are reasonable as part of a general psychiatric workup but are not diagnostic for gambling disorder.^[5]

Cognitive-behavioral therapy is the most consistently supported intervention; no medication carries an FDA indication for gambling disorder. Treatment is selected on the basis of comorbidity, urge intensity, and patient preference.^[12-13]

Pharmacotherapy

• Opioid antagonists are the best-supported pharmacologic option; naltrexone 50-150 mg PO QD reduced gambling urges and behavior in a placebo-controlled trial, with effect sizes generally small to moderate and possibly larger in patients with a family history of alcohol use disorder.^[7]
• Nalmefene has shown benefit in placebo-controlled trials in Europe but is not widely available in the US for this indication.^[11]
• SSRIs (fluvoxamine, paroxetine, sertraline, citalopram, escitalopram) have produced mixed results; evidence suggests benefit primarily when a comorbid anxiety or depressive disorder is the dominant clinical problem.^[11]
• Mood stabilizers (lithium, sustained-release lithium, topiramate) have limited supporting evidence; lithium is reasonable when bipolar spectrum pathology is comorbid.^[11]
• N-acetylcysteine and memantine have small positive trials; their place in routine practice is not established.^[11]
• Where dopamine-agonist exposure is causative, reducing or discontinuing the agonist is the primary intervention, ideally in coordination with neurology.^[4]

Psychotherapy

• Cognitive behavioral therapy targets gambling-specific cognitive distortions (gambler's fallacy, illusion of control, near-miss salience), develops alternative reinforcement, and builds relapse-prevention skills; evidence suggests it is the best-supported treatment with moderate effect sizes that diminish over follow-up.^[12-13]
• Motivational interviewing and brief motivational interventions produce small-to-moderate reductions in gambling behavior and can be delivered in primary care or single-session formats.^[12]
• Gamblers Anonymous (12-step) is widely available; observational data link sustained attendance to better abstinence outcomes, but it has not been rigorously tested against active comparators.^[5]
• Couples and family-based therapy improves engagement and addresses relational consequences; the concerned-significant-other model has been used successfully.^[13]
• Internet-delivered CBT and self-help workbooks show benefit in milder cases and can extend access where in-person care is limited.^[13]

Neuromodulation

• Repetitive transcranial magnetic stimulation and transcranial direct-current stimulation targeting dorsolateral prefrontal cortex have shown preliminary signals in small trials; evidence is insufficient for routine use.[CITE NEEDED]
• Deep brain stimulation has been described in case reports for severe refractory cases, exclusively within research protocols.[CITE NEEDED]

Adjunctive

• Financial counseling and debt management are integral; many patients require structured budgeting, third-party financial controls, and credit-card and online-account restrictions.^[5]
• Self-exclusion programs at casinos and online platforms are a low-burden harm-reduction step with reasonable observational support.^[2]
• Treat comorbid mood, anxiety, and substance use disorders concurrently; isolated gambling-only treatment is rarely sufficient.^[2-3]

Gambling disorder produces severe financial, relational, occupational, and medical harms; the treatment evidence base, while growing, is constrained by short follow-up, heterogeneous outcomes, and limited replication.^[2,12]

Direct harms of the disorder

• Suicide attempt rates in clinical samples are reported between roughly 17 and 24 percent, among the highest in psychiatry; suicidal ideation is more common still.^[2]
• Bankruptcy, foreclosure, and loss of housing are common; many patients commit illegal acts to fund gambling.^[3,5]
• Comorbid alcohol, nicotine, and other substance use disorders amplify medical morbidity and mortality.^[2-3]
• Family-level harms include domestic violence, child neglect, and elevated rates of psychiatric morbidity in spouses and children.^[3]

Treatment-related harms

• Naltrexone is associated with nausea, headache, fatigue, and dose-dependent hepatotoxicity; baseline and periodic liver-function monitoring is indicated, and concurrent opioid use is contraindicated.^[7]
• SSRIs carry class adverse effects including GI distress, sexual dysfunction, and a small risk of activation; abrupt discontinuation can produce a withdrawal syndrome.^[11]
• Lithium has a narrow therapeutic window with renal and thyroid effects; not first-line outside bipolar comorbidity.^[11]
• CBT carries minimal direct harm but is time-intensive, requires trained clinicians, and access is limited in many settings.^[12-13]

Limitations of the evidence

• Most psychotherapy trials are small, short, and use heterogeneous outcomes (frequency, money lost, days abstinent, severity scores).^[12-13]
• Pharmacologic trials are typically 8 to 16 weeks; long-term efficacy is poorly characterized.^[11]
• Most evidence comes from high-income Western settings; generalizability to other cultural contexts and to online-only gamblers is uncertain.^[2-3]
• Publication bias and industry funding in some surveillance and treatment studies are recognized concerns.^[2]

Risk profile, presentation, and management are modified by age, sex, comorbidity, and setting. The following adjustments matter at the bedside.^[2-3]

Adolescents and young adults

• Adolescents and young adults have the highest past-year prevalence of problem gambling in many surveys, driven by online platforms and accessible sports betting.^[2]
• Most US jurisdictions prohibit gambling under 18 or 21; legal context affects assessment and disclosure.^[5]
• Family-based interventions and school-based prevention have observational support; pharmacotherapy data in adolescents are sparse.^[5]

Older adults

• New-onset gambling in late life should prompt evaluation for dopamine-agonist exposure, frontal pathology, behavioral-variant frontotemporal dementia, and bipolar spectrum illness.^[4-5]
• Slot machines and bingo are the most common forms; isolation and bereavement are frequent precipitants.^[5]
• Cognitive screening (MMSE or MoCA) is reasonable in late-onset cases.^[5]

Women

• Women show later onset, telescoping (faster progression from initiation to disorder), and preferential use of non-strategic forms; they are more likely to present with comorbid mood and anxiety disorders.^[3]
• Stigma and caretaking obligations reduce treatment-seeking; gender-specific groups improve engagement.^[3]

Perinatal patients

• Data are limited; treatment generally favors psychotherapy over pharmacotherapy in pregnancy and lactation.^[6]
• Co-occurring substance use should be screened and addressed; financial stress in pregnancy is a relapse risk.^[6]

Patients with Parkinson disease and other dopamine-agonist exposure:

• Onset is typically within months of agonist initiation or dose increase; rotation to levodopa monotherapy or agonist taper is the primary intervention.^[4]
• Patients and families should be counseled at agonist initiation and screened at every neurology follow-up; the resolution of impulse-control behavior with agonist reduction is often dramatic.^[4]

Patients with substance use disorders

• Comorbidity is high; integrated treatment of both disorders produces better outcomes than sequential treatment.^[2-3]
• Alcohol use disorder is the most commonly co-occurring substance disorder and may strengthen the rationale for naltrexone.^[7]

Forensic populations

• Pathological gambling is over-represented in correctional populations; financial crimes (embezzlement, fraud, check forgery) are common antecedents.^[5]
• Court-mandated treatment can be effective, though randomized evidence is limited.^[5]

Course is variable; episodic and persistent patterns are both common, and a meaningful minority experience natural recovery. Comorbidity is the dominant prognostic factor.^[2-3]

Natural history

• Onset is most often in late adolescence or early adulthood for men and somewhat later for women, with chronicity and relapse the norm without treatment.^[2-3]
• Spontaneous recovery occurs in approximately one-third of community cases over several years, more often with milder severity and social support.^[2]

Treatment response

• Short-term response to CBT is moderate; sustained abstinence at one to two years is achieved by a substantial minority, with relapse rates of 50 percent or more.^[12-13]
• Pharmacologic response is modest at best; comorbidity drives most prescribing decisions.^[11]
• Engagement with Gamblers Anonymous is associated with better long-term outcomes in observational studies.^[5]

Mortality and functional outcome

• All-cause mortality is elevated, driven by suicide, comorbid substance use, and cardiovascular disease.^[2]
• Functional outcomes include enduring debt, family disruption, and occupational impairment that often persist after gambling itself has stopped.^[3]

Suicide risk is the dominant emergency consideration; financial crisis is a common, identifiable precipitant. Every assessment includes a structured suicide evaluation.^[2]

Suicide risk

• Lifetime suicide attempt rates in clinical samples are reported between approximately 17 and 24 percent; ideation is substantially more common.^[2]
• Major precipitants include large recent losses, foreclosure, divorce, and legal disclosure.^[2-3]
• Standard means-restriction counseling applies; restricting access to firearms, controlled medications, and credit and online-betting accounts is appropriate.^[5]

Hospitalization criteria

• Active suicidal ideation with plan or intent, recent attempt, or severe self-neglect warrants inpatient evaluation.^[5]
• Acute psychosocial crisis without a safe environment (no housing, active domestic violence) may warrant brief hospitalization for stabilization.^[5]
• Voluntary admission is preferred; involuntary criteria follow local mental health law.^[5]

Acute crisis management

• Coordinate with social work for emergency financial counseling and creditor contact.^[2]
• Engage Gamblers Anonymous or a problem-gambling helpline at discharge.^[5]
• Enrollment in casino and online self-exclusion programs is a low-burden harm-reduction step.^[2]

The field disagrees on the boundaries of behavioral addiction, on whether any pharmacotherapy meaningfully changes course, and on how to regulate rapidly expanding gambling environments.^[2-3]

Classification and scope

• Internet gaming disorder is included in DSM-5-TR Section III as a condition for further study; ICD-11 lists gaming disorder as a disorder due to addictive behaviors alongside gambling disorder.^[1,8]
• Whether other repetitive behaviors (shopping, sex, exercise) belong in the addiction framework is contested; current DSM-5-TR does not recognize them as disorders.^[1]
• The DSM-5 four-criterion threshold (lowered from five in DSM-IV) and the removal of the illegal acts criterion remain debated in the forensic literature.^[1,3]

Pharmacotherapy

• No agent has FDA approval for gambling disorder; meta-analyses report small-to-moderate effects for opioid antagonists and modest, heterogeneous effects for SSRIs.^[11]
• Whether to treat gambling disorder primarily as an addiction (favoring naltrexone) or to target comorbid mood-anxiety pathology (favoring SSRIs) shapes prescribing patterns across national traditions.^[11]
• The contribution of dopamine-agonist and partial-agonist exposure to general-population gambling disorder, beyond Parkinson disease, remains under-characterized.^[4,6]

Regulatory and public health

• Online and in-play sports betting have expanded markedly in jurisdictions that legalized them after the 2018 US Supreme Court decision in Murphy v. NCAA; population-level outcome data are still maturing.[CITE NEEDED]
• Industry-funded responsible-gambling messaging has been criticized as analogous to tobacco-industry harm-reduction campaigns; structural measures (deposit limits, advertising restrictions, mandatory pre-commitment) have stronger public-health support.[CITE NEEDED]
• Loot boxes and monetized game mechanics blur the line between gaming and gambling and have prompted regulatory action in several countries.[CITE NEEDED]

• Gambling disorder is the only behavioral addiction classified within the DSM-5-TR Substance-Related and Addictive Disorders chapter.^[1]
• Diagnosis requires at least 4 of 9 criteria over a 12-month period, with severity graded mild (4-5), moderate (6-7), or severe (8-9).^[1]
• Lifetime prevalence in the general adult population is approximately 0.4 to 1.0 percent, with a roughly 2:1 male predominance and earlier onset in men.^[2-3]
• Suicide attempts occur in roughly 17 to 24 percent of patients in clinical samples, among the highest rates of any psychiatric disorder.^[2]
• Dopamine agonists used in Parkinson disease (pramipexole, ropinirole, rotigotine) are a classic iatrogenic cause; impulse-control disorder prevalence reaches 5 to 8 percent on these agents.^[4]
• Cognitive-behavioral therapy is the best-supported treatment and targets gambling-specific cognitive distortions such as the gambler's fallacy and the illusion of control.^[12-13]
• Naltrexone has the strongest pharmacologic evidence base for reducing urges and gambling behavior, despite lacking FDA approval for this indication.^[7,11]
• The Lie/Bet Questionnaire is a 2-item screen with high sensitivity for case-finding in primary care and emergency settings.^[9]
• The South Oaks Gambling Screen (SOGS) is a 20-item self-report instrument; a cutoff of 5 or higher identifies probable pathological gambling.^[10]
• Comorbidity with substance use disorders, mood disorders, and Cluster B personality disorders is the rule rather than the exception.^[2-3]
• Chasing losses (returning another day to win back money lost) is a core diagnostic criterion and a marker of severity.^[1]
• DSM-5 reclassified pathological gambling (formerly an impulse-control disorder in DSM-IV) as gambling disorder within addictions, based on shared neurobiology with substance use disorders.^[1,3]
• ICD-11 lists gambling disorder and gaming disorder under disorders due to addictive behaviors; internet gaming disorder remains in DSM-5-TR Section III as a condition for further study.^[1,8]
• Aripiprazole and other partial dopamine agonists carry an FDA warning for new-onset pathological gambling.^[6]
• Always screen for suicidality in the gambler presenting with financial crisis; lethal-means counseling should include limiting access to firearms and securing finances.^[2,5]

No external funding. No conflicts of interest declared. Peer-review status: pending.